risperidone

(redirected from Risperdal Consta)
Also found in: Medical.
Related to Risperdal Consta: Invega Sustenna

ris·per·i·done

 (rĭ-spĕr′ə-dōn′)
n.
An oral antipsychotic drug, C28H27FN4O2, that is a dopamine and serotonin antagonist and is used to treat schizophrenia and bipolar disorder.

[Perhaps (fluo)r(obenz)is(oxazole), one of its constituents (fluoro- + benz- + is(o)- + ox- + azole) + (pi)perid(ine) + -one.]
Translations

risperidone

n risperidona
References in periodicals archive ?
Sales are then expected to decline between 2017 and 2023 due to the generic erosion of various brands including Otsuka's Abilify, Pfizer's Zeldox, Allergan's Saphris, and Janssen's Risperdal Consta.
RISPERDAL CONSTA sales were down 18% to $254 million.
Alkermes PLC will have diverse revenue streams from 25 commercialized products, with future near-term growth expected to be driven by five major products: Risperdal Consta, Invega Sustenna, Ampyra, Vivitrol and Bydureon.
29 March 2011 - Janssen EMEA, a company of US Johnson & Johnson (NYSE: JNJ), said last Friday that new data from an independent prospective study presented at the 19th European Congress of Psychiatry (EPA 2011) shows treatment with Risperdal Consta (risperidone long-acting injection (RLAI)) is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
Waikato DHB psychiatrist Wayne Miles outlined his study of the use of Risperdal Consta medication in a Polynesian population.
Johnson & Johnson (New Brunswick NJ) said it failed to win approval to market Risperdal Consta as a maintenance treatment to curb mood episodes in bipolar disorder patients with frequent relapses.
Risperdal Consta sales were down 7% to $358 million in the quarter, and down 10% for the year to $1.
Through adopting chemical synthesis technology, we plan to annually produce pioglitazone hydrochloride and its intermediates of 20 tons, cinepazide maleate of 3 tons, risperdal consta and its intermediates of 2 tons, oxcarbazepine and its intermediates of 3 tons, as well as zolmitriptan of 2 tons.
But those sales are being replaced by the company's Risperdal Consta, which had revenues of $1 billion from January to October.
Risperdal Consta sales were $319 million in the quarter (+8%) and $1.
The attorney general said a total of 37 states which include New Jersey have achieved a record $181 million dollar settlement with Janssen over the firm's alleged improper marketing of antipsychotic drugs Risperdal, Risperdal Consta, Risperdal M-Tab and Invega.
have applied to the FDA to sell a long-acting form of the drug, Risperdal Consta, for frequently relapsing bipolar disorder, defined as four or more manic episodes in the previous year.